Found: 7
Select item for more details and to access through your institution.
Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China.
- Published in:
- Stem Cells International, 2019, p. 1, doi. 10.1155/2019/4130757
- By:
- Publication type:
- Article
Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2020, p. 1, doi. 10.1155/2020/8872120
- By:
- Publication type:
- Article
Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2019, p. 1, doi. 10.1155/2019/2970510
- By:
- Publication type:
- Article
The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients.
- Published in:
- Gastroenterology Report, 2021, v. 9, n. 4, p. 313, doi. 10.1093/gastro/goab013
- By:
- Publication type:
- Article
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/3765937
- By:
- Publication type:
- Article
Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 10, p. 1071, doi. 10.1111/jvh.13319
- By:
- Publication type:
- Article
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2018, p. 1, doi. 10.1155/2018/1817680
- By:
- Publication type:
- Article